Labcorp Holdings is set to release its third-quarter earnings this month, and analysts anticipate solid double-digit growth ...

Labcorp Holdings ( ($LH) ) has issued an announcement. On October 8, 2025, Labcorp Holdings Inc. announced that its Board of Directors declared a ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies ...

On Tuesday, the College of Healthcare Information Management Executives (CHIME) held an event to launcha $1 millionglobal ...

In the assessment of 12-month price targets, analysts unveil insights for Labcorp Hldgs, presenting an average target of $297.5, a high estimate of $310.00, and a low estimate of $282.00. This current ...

Fintel reports that on October 3, 2025, Evercore ISI Group maintained coverage of Labcorp Holdings (NYSE:LH) with a ...

Quest Diagnostics can benefit from continued demand for specific diagnostic testing across a broad range of clinical areas.

Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.

Healthcare workers at Kaiser Permanente in Oregon and Southwest Washington are set to strike for five days beginning next ...

Areteia Therapeutics Inc., a clinical-stage biotechnology company based in Chapel Hill, has reported positive results from ...